Sleeve Lobectomy After Neoadjuvant Chemoimmunotherapy Versus Chemotherapy for Squamous Cell Lung Cancer: A Multicenter, Retrospective Study

Introduction: To analyze the feasibility and efficacy of sleeve lobectomy after neoadjuvant immunotherapy in multicenter patients with squamous cell lung cancer. Methods: We retrospectively identified patients who received neoadjuvant immunotherapy (n = 14) or chemotherapy alone (n = 33) at five tho...

Полное описание

Библиографические подробности

Главные авторы:	Tianxiang Chen, MD, PhD, Junwei Ning, MD, Jianfei Shen, MD, PhD, Hui Pan, MD, Linhai Fu, MD, Enwu Xu, MD, PhD, Han Wu, MD, Jia Huang, MD, PhD, Yunhai Yang, MD, PhD, Ziming Li, MD, PhD, Qingquan Luo, MD, PhD
Формат:	Artigo
Язык:	Inglês
Опубликовано:	Elsevier 2023-04-01
Серии:	JTO Clinical and Research Reports
Предметы:	Neoadjuvant therapy Sleeve lobectomy Squamous cell lung cancer PD-1 inhibitor
Online-ссылка:	http://www.sciencedirect.com/science/article/pii/S2666364323000115
Метки:	Добавить метку Нет меток, Требуется 1-ая метка записи!